DGFT notifies norms for Sodium Salicylate & Methylcobalamin

Both products are being exported by the drug industry.

Export Import
Picture: Pixabay

Last Updated on December 4, 2021 by The Health Master

The Director General of Foreign Trade (DGFT) has notified two new Standard Input Output Norms (SIONs) for exporting the following products under the Chemical and Allied product group:

  • Sodium salicylate
  • Methylcobalamin (Mecobalamin)

Both products are being exported by the drug industry.

Sodium salicylate is used in medicine as an analgesic and an antipyretic. It also acts as a non-steroidal anti-inflammatory drug (NSAID), and induces apoptosis in cancer cells and also necrosis.

On the other hand, methylcobalamin is used to treat vitamin B12 deficiency. Vitamin B12 is important for the brain and nerves, and for the production of red blood cells.

Methylcobalamin is sometimes used in people with pernicious anemia, diabetes, and other conditions.

According to a notification issued by DGFT on December 2, 2021, SIONs for export products—sodium salicylate and methylcobalamin under the Chemical and Allied Product Group have been notified.

SIONs are important for the import of raw materials required to make units of output for export purposes. It is applicable to a series of products, including pharmaceuticals.

There are several pharmaceutical products where SIONs are not available causing inconvenience to exporters.

The DGFT fixes / reviews the SIONs for various bulk drugs and formulations on the basis of date/applications received from pharmaceutical exporters. The applications are considered by the Norms Committee (NC) headed by the Exports Commissioner in the DGFT office in Delhi.

The Pharmaceutical Export Promotion Council of India (Pharmexcil) is a member of the Committee and DGFT regularly takes help from Pharmexcil for fast disposal of applications.

SION is notified by DGFT in the Handbook, and is affirmed by its boards of directors. An application for change of existing SION might be recorded by the exporter. The DGFT now and again issues warnings for obsessive or excessive use of SION for various fare items.

Obsession of SION norms encourages issuance of Advance License to the exporters of the products with no requirement for referring the same to the DGFT headquarters.

DGFT specifies the number of inputs allowed for any given product by issuing a sector-wise list of SION. It spells out the required quantity of inputs needed for specific products, while also taking into account any wastage that may occur during manufacturing.

In cases where SION norms are not present, exporters have to wait for a longer period of time to get SION fixed in the norms committee, resulting in delays in the fulfillment of export orders.

Govt asks States to collaborate with proposed Medical Devices Parks

Morepen gets USFDA nod for anti-allergy drug

Roche develops new research Test Kits for Omicron variant

Booster dose of these 6 Vaccines safe, increases immunity: Study

NPPA to hire 33 professionals for various levels of its operations

Govt to amend Drug Rules for list of colours permitted to…

NPPA fixes retail price of 47 formulations: November 2021

WHO issues these guidelines regarding Omicron

Govt amends Drugs Rules on Import Licence and registration certificate

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner